Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
NCT00625079Phase 4Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ASP-001 in pulmonary hypertension (PH), sponsored by University of California, Los Angeles. Planned start Feb 2007; status: withdrawn.
02
Drugs
ASP-001
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00625079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625079.